CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
CarlC Awh, Anne-Marie Lane, Steven Hawken, Brent Zanke, IvanaK Kim
Index: Ophthalmology 120(11) , 2317-23, (2013)
Full Text: HTML
Abstract
The Age-Related Eye Disease Study (AREDS) demonstrated that antioxidant and zinc supplementation decreases progression to advanced age-related macular degeneration (AMD) in patients with moderate to severe disease. We evaluated the interaction of genetics and type of nutritional supplement on progression from moderate to advanced AMD.
Related Compounds
Related Articles:
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2010-07-23
[J. Nat. Prod. 73 , 1193-5, (2010)]
2008-01-01
[Toxicol. Mech. Methods 18 , 217-27, (2008)]
2014-12-01
[Lung Cancer 86(3) , 297-303, (2014)]
2014-07-28
[Br. J. Nutr. 112(2) , 162-9, (2014)]